• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL TRIFECTA¿ GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL TRIFECTA¿ GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TFGT-A
Medical Device Problem Codes Degraded (1153); Incomplete Coaptation (2507)
Health Effect - Clinical Codes Valvular Insufficiency/ Regurgitation (4449); Aortic Valve Insufficiency/ Regurgitation (4450)
Date of Event 04/15/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that in (b)(6) 2019, a 29mm trifecta gt valve was implanted.The patient later presented with symptoms of severe aortic regurgitation.The patient underwent a transcatheter aortic valve implantation on (b)(6) 2022, and a 29mm non-abbott valve was implanted within the trifecta valve.No additional information was provided.
 
Additional Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Implant date has been estimated to (b)(6) 2019.
 
Additional Manufacturer Narrative
An event of regurgitation was reported.A returned device assessment and histopathological examination could not be performed as the device remains implanted as a valve-in-valve procedure was performed and the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.H6 health effect - clinical code 4449 was removed and code 4450 was added h6 medical device problem code 1153 was removed and code 2507 was added.
 
Event or Problem Description
It was reported that in(b)(6).2019, a 29mm trifecta gt valve was implanted.The patient later presented with symptoms of severe aortic regurgitation.The patient underwent a transcatheter aortic valve implantation on 14 april 2022, and a 29mm non-abbott valve was implanted within the trifecta valve via valve-in-valve procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIFECTA¿ GT VALVE
Common Device Name
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key14426950
Report Number2135147-2022-00285
Device Sequence Number6530404
Product Code LWR
UDI-Device Identifier05415067018250
UDI-Public05415067018250
Combination Product (Y/N)N
Initial Reporter StateNC
Initial Reporter CountryUS
PMA/510(K) Number
P100029
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/18/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date05/27/2022
Device Model NumberTFGT-A
Device Catalogue NumberTFGT-29A
Device Lot Number6500985
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 04/19/2022
Supplement Date Received by Manufacturer06/21/2022
Initial Report FDA Received Date05/17/2022
Supplement Report FDA Received Date07/18/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured05/28/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age75 YR
Patient SexMale
-
-